QLIFE logo

Qlife Holding AB (publ) Stock Price

OM:QLIFE Community·SEK 65.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

QLIFE Share Price Performance

SEK 2.28
0.41 (22.25%)
SEK 2.28
0.41 (22.25%)
Price SEK 2.28

QLIFE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with imperfect balance sheet.

6 Risks
0 Rewards

Qlife Holding AB (publ) Key Details

SEK 324.0k

Revenue

SEK 994.0k

Cost of Revenue

-SEK 670.0k

Gross Profit

SEK 19.9m

Other Expenses

-SEK 20.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 01, 2026
-0.71
-206.79%
-6,345.06%
-113.9%
View Full Analysis

About QLIFE

Founded
2019
Employees
4
CEO
Thomas Warthoe
WebsiteView website
www.qlifeholding.com

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vitami, and D-dimer. Qlife Holding AB (publ) was incorporated in 2019 and is based in Helsingborg, Sweden.

Recent QLIFE News & Updates

Recent updates

No updates